Literature DB >> 19544152

Effect of plasma proteins on buprenorphine transfer across dually perfused placental lobule.

Tatiana N Nanovskaya1, Robin S Bowen, Svetlana L Patrikeeva, Gary D V Hankins, Mahmoud S Ahmed.   

Abstract

OBJECTIVE: The aim of this investigation is to determine the effect of human serum albumin (HSA) and alpha-acid glycoprotein (AAG) on buprenorphine (BUP) transplacental transfer and distribution.
METHODS: The technique of dual perfusion of placental lobule (DPPL) was utilised. BUP was co-perfused with the marker compound antipyrine (AP). In each experiment, the radiolabelled isotopes [(3)H]-BUP and [(14)C]-AP were added to enhance their detection limits. Human plasma proteins, HSA and AAG, were added to both the maternal and fetal circuits separately and in combination at their physiological concentrations in maternal and fetal circulations close to term.
RESULTS: Transplacental transfer of BUP, in absence of plasma proteins, is a two-step process: the first is its uptake by the syncytiotrophoblast from the maternal circuit, and the second is its transfer/release from the tissue to the fetal circuit. The addition of HSA to the perfusion medium affected only the second step of BUP transfer, but AAG affected both steps. The combined effect of HSA and AAG was not different from that observed in presence of the latter alone.
CONCLUSIONS: Binding of BUP to circulating AAG could have an important role in the transfer of the drug from the maternal to fetal circulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544152      PMCID: PMC4435547          DOI: 10.1080/14767050802610328

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  19 in total

1.  [Pregnancy, abortion and delivery in a cohort of heroin dependent patients treated with drug substitution (methadone and buprenorphine) in Aquitaine].

Authors:  M Auriacombe; S Afflelou; P Lavignasse; C Lafitte; D Roux; J P Daulouède; J Tignol
Journal:  Presse Med       Date:  1999-01-30       Impact factor: 1.228

2.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Authors:  D R Jasinski; J S Pevnick; J D Griffith
Journal:  Arch Gen Psychiatry       Date:  1978-04

3.  Cost-effectiveness of treatment for drug-abusing pregnant women.

Authors:  D S Svikis; A S Golden; G R Huggins; R W Pickens; M E McCaul; M L Velez; C T Rosendale; R K Brooner; P M Gazaway; M L Stitzer; C E Ball
Journal:  Drug Alcohol Depend       Date:  1997-04-14       Impact factor: 4.492

4.  Protein binding predictions in infants.

Authors:  Patrick J McNamara; Jane Alcorn
Journal:  AAPS PharmSci       Date:  2002

5.  Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.

Authors:  Reinhold Jagsch; Wolfgang Gombas; Shird-Dieter Schindler; Harald Eder; David E Moody; Gabriele Fischer
Journal:  Addict Biol       Date:  2005-12       Impact factor: 4.280

6.  Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.

Authors:  Hendree E Jones; Rolley E Johnson; Donald R Jasinski; Kevin E O'Grady; Christian A Chisholm; Robin E Choo; Michael Crocetti; Robert Dudas; Cheryl Harrow; Marilyn A Huestis; Lauren M Jansson; Michael Lantz; Barry M Lester; Lorraine Milio
Journal:  Drug Alcohol Depend       Date:  2005-07       Impact factor: 4.492

Review 7.  Use of buprenorphine in pregnancy: patient management and effects on the neonate.

Authors:  Rolley E Johnson; Hendrée E Jones; Gabriele Fischer
Journal:  Drug Alcohol Depend       Date:  2003-05-21       Impact factor: 4.492

8.  Effect of albumin on transplacental transfer and distribution of rosiglitazone and glyburide.

Authors:  Tatiana N Nanovskaya; Svetlana Patrikeeva; Sarah Hemauer; Valentina Fokina; Donald Mattison; Gary D Hankins; Mahmoud S Ahmed
Journal:  J Matern Fetal Neonatal Med       Date:  2008-03

9.  Differential effects of maternal heroin and methadone use on birthweight.

Authors:  S R Kandall; S Albin; J Lowinson; B Berle; A I Eidelman; L M Gartner
Journal:  Pediatrics       Date:  1976-11       Impact factor: 7.124

10.  Aromatase is the major enzyme metabolizing buprenorphine in human placenta.

Authors:  Sujal V Deshmukh; Tatiana N Nanovskaya; Mahmoud S Ahmed
Journal:  J Pharmacol Exp Ther       Date:  2003-06-13       Impact factor: 4.030

View more
  1 in total

1.  Sulfation of Lower Chlorinated Polychlorinated Biphenyls Increases Their Affinity for the Major Drug-Binding Sites of Human Serum Albumin.

Authors:  Eric A Rodriguez; Xueshu Li; Hans-Joachim Lehmler; Larry W Robertson; Michael W Duffel
Journal:  Environ Sci Technol       Date:  2016-05-04       Impact factor: 9.028

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.